<p>Mice were immunized twice, three weeks apart, with MVA vectors and challenged three weeks later with (<b>A and B</b>) 42 LD<sub>50</sub> of H5N1 VN1203, (<b>C</b>) 32 LD<sub>50</sub> of mouse-adapted H9N2 HK/G9 or (<b>D</b>) 16 LD<sub>50</sub> of H7N1 RO/34. (<b>B</b>) Primed mice were infected intranasally with 100 TCID<sub>50</sub> H1N1pdm09 virus, six weeks before immunization. Animals were monitored for 14 days after challenge. Shown are the daily variations in weight, as percentages compared to before virus challenge.</p
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>BALB/c mice were intranasally inoculated with A/Egret/Hunan/1/2012, A/Chicken/Hunan/12/2011 virus...
<p>BALB/c mice (n = 5/group) were immunized twice on day 0 and 16 with 3×10<sup>6</sup> PFU or 3×10<...
<p>Mice were immunized twice, three weeks apart, with MVA vectors and challenged three weeks later w...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p><b>Mice (n = 6/groups) were immunized intranasally on day 0 and 28.</b> All groups were challenge...
<p>C57BL/6 mice <b>(A)</b> and BALB/c mice <b>(B)</b> were challenged i.n. with 1*10<sup>5</sup> TCI...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>Mice (n = 8) were vaccinated intranasally with Flu-NA-DIII (•) or Flu-NA-GFP (○) or by the subcut...
<p>The mice were challenged with 10<sup>4.5</sup> TCID<sub>50</sub> H7N9 virus (10 MLD<sub>50</sub>)...
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>BALB/c mice were intranasally inoculated with A/Egret/Hunan/1/2012, A/Chicken/Hunan/12/2011 virus...
<p>BALB/c mice (n = 5/group) were immunized twice on day 0 and 16 with 3×10<sup>6</sup> PFU or 3×10<...
<p>Mice were immunized twice, three weeks apart, with MVA vectors and challenged three weeks later w...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p><b>Mice (n = 6/groups) were immunized intranasally on day 0 and 28.</b> All groups were challenge...
<p>C57BL/6 mice <b>(A)</b> and BALB/c mice <b>(B)</b> were challenged i.n. with 1*10<sup>5</sup> TCI...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>Mice (n = 8) were vaccinated intranasally with Flu-NA-DIII (•) or Flu-NA-GFP (○) or by the subcut...
<p>The mice were challenged with 10<sup>4.5</sup> TCID<sub>50</sub> H7N9 virus (10 MLD<sub>50</sub>)...
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>BALB/c mice were intranasally inoculated with A/Egret/Hunan/1/2012, A/Chicken/Hunan/12/2011 virus...
<p>BALB/c mice (n = 5/group) were immunized twice on day 0 and 16 with 3×10<sup>6</sup> PFU or 3×10<...